Functions of CD40 on B cells, dendritic cells and other cells

https://doi.org/10.1016/S0952-7915(97)80078-7Get rights and content

Abstract

CD40 is a cell surface receptor that belongs to the tumor necrosis factor receptor family. It was first identified and functionally characterized on B lymphocytes; however, in recent years it has become clear that CD40 expression is much broader, as it is found on monocytes, dendritic cells, hematopoietic progenitors, endothelial cells and epithelial cells. Although initially identified for its activation properties, CD40 is also able to transduce negative signals in various cell types. It is presently accepted that CD40 plays a critical role in the regulation of immune responses. The past year has seen considerable progress in the identification of intracellular molecules mediating CD40 signaling. Furthermore, it has been established that ligation of CD40 ligand (CD40L) delivers signals to the CD40L bearing cells themselves. Finally, the critical role of CD40-CD40L interactions in the development of various disease states has been fully appreciated.

References (64)

  • IS Grewal et al.

    Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis

    Science

    (1996)
  • TM Foy et al.

    Immune regulation by CD40 and its ligand gp39

    Annu Rev Immunol

    (1996)
  • RJ Noelle

    CD40 and its ligand in host defense

    Immunity

    (1996)
  • RD Stout et al.

    The many roles of CD40 in cell-mediated inflammatory responses

    Immunol Today

    (1996)
  • CA Smith et al.

    The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death

    Cell

    (1994)
  • AC Grammer et al.

    The CD40 ligand expressed by human B cells costimulates B cells responses

    J Immunol

    (1995)
  • MR Kehry

    CD40-mediated signaling in B cells

    J Immunol

    (1996)
  • I Berberich et al.

    Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases

    EMBO J

    (1996)
  • YY Li et al.

    CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells

    J Immunol

    (1996)
  • E Gulbins et al.

    Activation of the Ras signaling pathway by the CD40 receptor

    J Immunol

    (1996)
  • CL Sutherland et al.

    Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor

    J Immunol

    (1996)
  • G Cheng et al.

    Involvement of CRAF1, a relative of TRAF, in CD40 signaling

    Science

    (1995)
  • HM Hu et al.

    A novel RING finger protein interacts with the cytoplasmic domain of CD40

    J Biol Chem

    (1994)
  • G Mosialos et al.

    The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor family

    Cell

    (1995)
  • T Sato et al.

    A novel member of the TRAF family of putative signal transducing proteins binds to the cytoplasmic domain of CD40

    FEBS Lett

    (1995)
  • U Zimber-Strobl et al.

    Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival

    EMBO J

    (1996)
  • Y Xu et al.

    Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses

    Immunity

    (1996)
  • M Rothe et al.

    TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40

    Science

    (1995)
  • J Banchereau et al.

    The CD40 antigen and its ligand

    Annu Rev Immunol

    (1994)
  • P Garrone et al.

    Fas ligation induces apoptosis of CD40-activated human B lymphocytes

    J Exp Med

    (1995)
  • EJ Schattner et al.

    CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway

    J Exp Med

    (1995)
  • TL Rothstein et al.

    Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells

    Nature

    (1995)
  • Cited by (413)

    • An optimally designed anti-human CD40 antibody with potent B cell suppression for the treatment of autoimmune diseases

      2021, International Journal of Pharmaceutics
      Citation Excerpt :

      CD40-CD40L interactions play a crucial role in T-dependent B-cell costimulation (Elgueta et al., 2009). CD40 is a 48-kDa type I membrane glycoprotein of the tumor necrosis factor (TNF) receptor superfamily expressed on B cells, dendritic cells, monocytes, macrophages, fibroblasts, endothelial cells, and epithelial cells (Banchereau et al., 1995; Bourgeois et al., 2002; Lee et al., 2014; vanKooten and Banchereau, 2000, 1997). Since its discovery on bladder carcinoma cells in 1985 by Paulie et al. (Paulie et al., 1985), CD40′s function has been extensively studied.

    View all citing articles on Scopus
    View full text